Charles Sternberg, Assistant Editor05.21.21
The Uplifters' Prima PBC, a purpose-driven brand focused on efficacy-driven and science-backed plant therapeutics and cannabinoids, has closed a $9.2 million Seed Plus financing led by Greycroft, H Ventures, Defy, and Lerer Hippeau, with notable participation from Adam Zeplain, Global Founders Capital, Emerald Health, One Gun, and Purple Arch Ventures.
Prima was launched in 2019 by Christopher Gavigan, bestselling author, purpose-driven entrepreneur, and co-founder of The Honest Company, Jessica Assaf, women's health and cannabis activist, and Laurel Angelica Myers mission-oriented operator and former Honest alum.
“With this meaningful funding, Prima will continue its focused investments in plant-driven, clean formulation science, R&D ownership, efficacy validation, operational infrastructure, sustainability initiatives and tech-enabled consumer experiences. Prima is even more emboldened to broaden our digital and retail strategies, build best-in-class education partnerships and ensure these therapeutic botanical compounds are destigmatized, understood and accessible for all," said Christopher Gavigan, Prima founder and CEO.
Prima now offers 15 "whole body care" products across premium skincare, body care and supplements that unlock the therapeutic utility and power of organic, broad spectrum plant ingredients for everyday consumers seeking immediate functional benefits with recovery, performance, mood, sleep and overall well-being.
With the brand's vast CPG expertise, team of medical advisors, national retail partnerships with Sephora, Nordstrom and over 800 new retail doors opening in 2021, Prima has legitimized the cannabinoid category for major retailers with its strong regulatory, testing and compliance validation and consumer-centric approach to product excellence.
"With so many new brands entering the CBD market, we strongly invite and encourage the FDA and Congressional regulators to legislate and be more proactive in taking swifter action to protect consumer safety, which in turn will further accelerate the acceptance and advancement of this critical healthcare industry," said Jessica Assaf, Prima's co-founder and chief education officer.
Prima was launched in 2019 by Christopher Gavigan, bestselling author, purpose-driven entrepreneur, and co-founder of The Honest Company, Jessica Assaf, women's health and cannabis activist, and Laurel Angelica Myers mission-oriented operator and former Honest alum.
“With this meaningful funding, Prima will continue its focused investments in plant-driven, clean formulation science, R&D ownership, efficacy validation, operational infrastructure, sustainability initiatives and tech-enabled consumer experiences. Prima is even more emboldened to broaden our digital and retail strategies, build best-in-class education partnerships and ensure these therapeutic botanical compounds are destigmatized, understood and accessible for all," said Christopher Gavigan, Prima founder and CEO.
Prima now offers 15 "whole body care" products across premium skincare, body care and supplements that unlock the therapeutic utility and power of organic, broad spectrum plant ingredients for everyday consumers seeking immediate functional benefits with recovery, performance, mood, sleep and overall well-being.
With the brand's vast CPG expertise, team of medical advisors, national retail partnerships with Sephora, Nordstrom and over 800 new retail doors opening in 2021, Prima has legitimized the cannabinoid category for major retailers with its strong regulatory, testing and compliance validation and consumer-centric approach to product excellence.
"With so many new brands entering the CBD market, we strongly invite and encourage the FDA and Congressional regulators to legislate and be more proactive in taking swifter action to protect consumer safety, which in turn will further accelerate the acceptance and advancement of this critical healthcare industry," said Jessica Assaf, Prima's co-founder and chief education officer.
